Table 4.
SSTR2C | |||
---|---|---|---|
Positive tumors | Negative tumors | P value | |
Ki-67 (%) | 5.8 (0–30) | 3.1 (0–40) | 0.069 |
Tumor size (cm) | 2.48 (1.0–4.0) | 2.0 (1.0–5.0) | 0.142 |
S-Ca-ion (mmol/L) | 1.69 (1.38–2.42) | 1.56 (1.28–2.58) | 0.098 |
S-PTH (ng/l) | 727 (34–2001) | 514 (68–4000) | 0.198 |
SSTR3N | |||
Positive tumors | Negative tumors | P value | |
Ki-67 | 5.6 (0–20) | 3.1 (0–40) | 0.003a |
Tumor size (cm) | 2.54 (1.0–4.0) | 2.0 (1–5) | 0.09 |
S-Ca-ion (mmol/L) | 1.63 (1.32–2.02) | 1.56 (1.28–2.58) | 0.107 |
S-PTH (ng/L) | 1049 (147–2769) | 461 (34–4000) | 0.003a |
SSTR4C | |||
Positive tumors | Negative tumors | P value | |
Ki-67 | 4.1 (0–40) | 3.1 (0–40) | 0.048a |
Tumor size (cm) | 2.2 (1.0–5.0) | 2.0 (1.0-5.0) | 0.607 |
S-Ca-ion (mmol/L) | 1.60 (1.29–2.58) | 1.55 (128–2.42) | 0.142 |
S-PTH (ng/L) | 613 (68–4000) | 485 (34–2220) | 0.139 |
SSTR4N | |||
Positive tumors | Negative tumors | P value | |
Ki-67 | 4.1 (0.40) | 3.0 (0–30) | 0.225 |
Tumor size (cm) | 2.23 (1–5) | 2.0 (1.0–4.0) | 0.825 |
S-Ca-ion (mmol/L) | 1.57 (1.29–2.04) | 1.58 (128–2.58) | 0.487 |
S-PTH (ng/L) | 580 (34–2220) | 500 (68–4000) | 0.258 |
SSTR5C | |||
Positive tumors | Negative tumors | P value | |
Ki-67 | 4.0 (0–40) | 1.4 (0–30) | <0.001a |
Tumor size (cm) | 2.20 (1.0–5.0) | 2.0 (1.0–5.0) | 0.135 |
S-Ca-ion (mmol/L) | 1.68 (1.32–2.58) | 1.45 (1.28–2.42) | <0.001a |
S-PTH (ng/L) | 634 (34–4000) | 173 (73–2210) | <0.001a |
SSTR5N | |||
Positive tumors | Negative tumors | P value | |
Ki-67 | 0.0 (0–40) | 0.0 (0–10) | 0.267 |
Tumor size (cm) | 2.0 (1.0–5.0) | 2.0 (1.0–4.0) | 0.079 |
S-Ca-ion (mmol/L) | 1.52 (1.28–2.58) | 1.45 (1.29–1.85) | 0.141 |
S-PTH(ng/L) | 264 (34–4000) | 188 (77–2220) | 0.230 |
aSignificant P values.